MGMT and focal segmental glomerulosclerosis: We also compared the MGMT promoter methylation, IDH, and H3K27M mutation status between the two groups and found that, apart from a trend towards unmethylated lesions being more common in the FGS group (without statistical significance), there were no differences in the glioma molecular profiling between the two groups (Table 1).